Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Yang

Showing results (181-190 of 193) with videos related to

Pageof 20
Sort By:
Journal of Medicinal Chemistry|May 27, 2011
Phospshoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitors: discovery and structure-activity relationships of a series of quinoline and quinoxaline derivativesNobuko Nishimura, Aaron Siegmund, Longbin Liu, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2006
A new class of bradykinin 1 receptor antagonists containing the piperidine acetic acid tetralin coreChristopher Fotsch, Gloria Biddlecome, Kaustav Biswas, et al.
Gynecologic Oncology|May 22, 2022
Homologous recombination deficiency (HRD) signature-3 in ovarian and uterine carcinosarcomas correlates with preclinical sensitivity to Olaparib, a poly (adenosine diphosphate [ADP]- ribose) polymerase (PARP) inhibitorJoan R Tymon-Rosario, Paola Manara, Diego D Manavella, et al.
Cell|February 22, 2020
A Deep Learning Approach to Antibiotic DiscoveryJonathan M Stokes, Kevin Yang, Kyle Swanson, et al.
Cell|April 18, 2020
A Deep Learning Approach to Antibiotic DiscoveryJonathan M Stokes, Kevin Yang, Kyle Swanson, et al.
Bioorganic & Medicinal Chemistry Letters|April 26, 2011
3-Oxo-2-piperazinyl acetamides as potent bradykinin B1 receptor antagonists for the treatment of pain and inflammationJian Jeffrey Chen, Thomas Nguyen, Derin C D'Amico, et al.
Gynecologic Oncology|March 23, 2023
Uterine leiomyosarcomas harboring MAP2K4 gene amplification are sensitive in vivo to PLX8725, a novel MAP2K4 inhibitorBlair McNamara, Justin Harold, Diego Manavella, et al.
Journal of Medicinal Chemistry|February 22, 2011
Discovery and optimization of a series of benzothiazole phosphoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitorsNoel D D'Angelo, Tae-Seong Kim, Kristin Andrews, et al.
Nature Chemical Biology|June 23, 2025
A class of benzofuranoindoline-bearing heptacyclic fungal RiPPs with anticancer activitiesQiuyue Nie, Fanglong Zhao, Xuerong Yu, et al.
ACS Medicinal Chemistry Letters|September 19, 2019
Discovery of <i>N</i>-(1-Acryloylazetidin-3-yl)-2-(1<i>H</i>-indol-1-yl)acetamides as Covalent Inhibitors of KRAS<sup>G12C</sup>Youngsook Shin, Joon Won Jeong, Ryan P Wurz, et al.
Pageof 20

Showing results (181-190 of 193) with videos related to

Sort By:
Pageof 20
Journal of Medicinal Chemistry|May 27, 2011
Phospshoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitors: discovery and structure-activity relationships of a series of quinoline and quinoxaline derivativesNobuko Nishimura, Aaron Siegmund, Longbin Liu, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2006
A new class of bradykinin 1 receptor antagonists containing the piperidine acetic acid tetralin coreChristopher Fotsch, Gloria Biddlecome, Kaustav Biswas, et al.
Gynecologic Oncology|May 22, 2022
Homologous recombination deficiency (HRD) signature-3 in ovarian and uterine carcinosarcomas correlates with preclinical sensitivity to Olaparib, a poly (adenosine diphosphate [ADP]- ribose) polymerase (PARP) inhibitorJoan R Tymon-Rosario, Paola Manara, Diego D Manavella, et al.
Cell|February 22, 2020
A Deep Learning Approach to Antibiotic DiscoveryJonathan M Stokes, Kevin Yang, Kyle Swanson, et al.
Cell|April 18, 2020
A Deep Learning Approach to Antibiotic DiscoveryJonathan M Stokes, Kevin Yang, Kyle Swanson, et al.
Bioorganic & Medicinal Chemistry Letters|April 26, 2011
3-Oxo-2-piperazinyl acetamides as potent bradykinin B1 receptor antagonists for the treatment of pain and inflammationJian Jeffrey Chen, Thomas Nguyen, Derin C D'Amico, et al.
Gynecologic Oncology|March 23, 2023
Uterine leiomyosarcomas harboring MAP2K4 gene amplification are sensitive in vivo to PLX8725, a novel MAP2K4 inhibitorBlair McNamara, Justin Harold, Diego Manavella, et al.
Journal of Medicinal Chemistry|February 22, 2011
Discovery and optimization of a series of benzothiazole phosphoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitorsNoel D D'Angelo, Tae-Seong Kim, Kristin Andrews, et al.
Nature Chemical Biology|June 23, 2025
A class of benzofuranoindoline-bearing heptacyclic fungal RiPPs with anticancer activitiesQiuyue Nie, Fanglong Zhao, Xuerong Yu, et al.
ACS Medicinal Chemistry Letters|September 19, 2019
Discovery of <i>N</i>-(1-Acryloylazetidin-3-yl)-2-(1<i>H</i>-indol-1-yl)acetamides as Covalent Inhibitors of KRAS<sup>G12C</sup>Youngsook Shin, Joon Won Jeong, Ryan P Wurz, et al.
Pageof 20